Genesis Drug Discovery & Development
@gd3services.com
Genesis Drug Discovery and Development (GD3), a member of Genesis Global Group, is a contract research organization focused on providing services to support preclinical drug development programs from discovery to candidate selection. Our diversified portfolio of services covers all the areas of preclinical drug discovery/development including Discovery Biology, Chemistry, DMPK/in-vivo pharmacology and Toxicology. The portfolio spans a wide range of therapeutic areas include oncology, ocular, inflammation, metabolic diseases, and microbiome.
Genesis Drug Discovery & Development's Company Logos
Genesis Drug Discovery & Development's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#7B705F
Pablo
123, 112, 95
36, 13, 43
0, 9, 23, 52
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#6F1401
Cedar Wood Finish
111, 20, 1
10, 98, 22
0, 82, 99, 56
About Genesis Drug Discovery & Development
Genesis Drug Discovery & Development (GD³) is a fully integrated Contract Research Organization (CRO) dedicated to supporting drug discovery programs. As a proud member of Genesis Drug Discovery & Development (GD3), GD³ offers a range of services from target discovery to IND filing and manages Phase I-III clinical trials. With decades of Pharma and CRO experience, GD³ leverages its expertise to advance therapeutic programs for the benefit of patients and their physicians.
GD³ provides a comprehensive suite of services, including Discovery Biology, Chemistry, ADME/Bioanalytical, and In-vivo Pharmacology. They also offer compound collections and specialize in areas such as ADC Synthesis, Bioconjugation, Biosimilars, Cancer Treatment, Diabetes Animal Model, Medicinal Chemistry, and Small Molecule Synthesis, among others. GD³ is committed to partnering with clients, inviting them to explore collaboration opportunities.
By combining their scientific knowledge and resources with client-driven research, GD³ aims to advance drug discovery and pre-clinical drug development, ultimately benefiting patients worldwide. For more information, visit the GD³ website
Company type
Privately Held
Year founded
2017
Company size
2-10 employees
